BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12193851)

  • 1. In-vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer.
    Lee SH; Szinai I; Carpenter K; Katsarava R; Jokhadze G; Chu CC; Huang Y; Verbeken E; Bramwell O; De Scheerder I; Hong MK
    Coron Artery Dis; 2002 Jun; 13(4):237-41. PubMed ID: 12193851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent-based tempamine delivery on neointimal formation in a porcine coronary model.
    Huang Y; Wang L; Li S; Liu X; Lee K; Verbeken E; van de Werf F; de Scheerder I
    Acute Card Care; 2006; 8(4):210-6. PubMed ID: 17162547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
    Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo.
    Nishimiya K; Matsumoto Y; Uzuka H; Ogata T; Hirano M; Shindo T; Hasebe Y; Tsuburaya R; Shiroto T; Takahashi J; Ito K; Shimokawa H
    JACC Cardiovasc Interv; 2016 Feb; 9(3):281-291. PubMed ID: 26847120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
    Uurto I; Mikkonen J; Parkkinen J; Keski-Nisula L; Nevalainen T; Kellomäki M; Törmälä P; Salenius JP
    J Endovasc Ther; 2005 Jun; 12(3):371-9. PubMed ID: 15943514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
    Wilson GJ; Marks A; Berg KJ; Eppihimer M; Sushkova N; Hawley SP; Robertson KA; Knapp D; Pennington DE; Chen YL; Foss A; Huibregtse B; Dawkins KD
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E247-57. PubMed ID: 26009986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents.
    Henn C; Satzl S; Christoph P; Kurz P; Radeleff B; Stampfl U; Stampfl S; Berger I; Richter GM
    J Vasc Interv Radiol; 2008 Mar; 19(3):427-37. PubMed ID: 18295704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
    Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
    Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
    Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
    EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model.
    Pérez de Prado A; Pérez Martínez C; Cuellas Ramón C; Regueiro Purriños M; López Benito M; Gonzalo Orden JM; Rodríguez Altónaga JA; Estévez Loureiro R; Benito González T; Viñuela Baragaño D; Molina Crisol M; Amorós Aguilar M; Pérez Serranos I; Vidal Parreu A; Benavides Montegordo A; Duocastella Codina L; Fernández Vázquez F
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1059-1066. PubMed ID: 28647315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries.
    De Scheerder IK; Wilczek KL; Verbeken EV; Vandorpe J; Lan PN; Schacht E; De Geest H; Piessens J
    Atherosclerosis; 1995 Apr; 114(1):105-14. PubMed ID: 7605369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
    Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
    Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
    Christiansen EH; Jensen LO; Thayssen P; Tilsted HH; Krusell LR; Hansen KN; Kaltoft A; Maeng M; Kristensen SD; Bøtker HE; Terkelsen CJ; Villadsen AB; Ravkilde J; Aarøe J; Madsen M; Thuesen L; Lassen JF;
    Lancet; 2013 Feb; 381(9867):661-9. PubMed ID: 23374649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model.
    Nakazawa G; Shinke T; Ijichi T; Matsumoto D; Otake H; Torii S; Hiranuma N; Ohsue T; Otsuka F; Shite J; Hirata K; Ikari Y
    EuroIntervention; 2014 Oct; 10(6):717-23. PubMed ID: 25330504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.